期刊文献+

洛铂对卵巢癌裸鼠移植瘤的抑制作用和对凋亡相关基因调控的研究 被引量:2

Inhibitory effects of lobaplatin on human ovarian cancer and its regulation of apoptosis-related genes in nude mice
原文传递
导出
摘要 目的探讨洛铂(LBP)、顺铂(DDP)对卵巢癌裸鼠移植瘤的生长抑制作用及对相关凋亡基因的调控。方法选用人卵巢癌细胞株SKOV3接种于裸小鼠皮下成瘤。将成瘤裸鼠按随机数字表法分为对照组、洛铂组和顺铂组,每组7只,洛铂组给予洛铂5mg/kg,顺铂组给予顺铂5mg/kg,于荷瘤成功后第1天、第8天和第15天经腹腔给药,每周3次记录瘤体体积和裸鼠体质量,并计算抑瘤率,用流式细胞学技术检测移植瘤组织的凋亡相关基因蛋白bax、bcl-2的表达。结果洛铂组的抑瘤率47.2%,顺铂组的抑瘤率42.8%,两组比较差异无统计学意义(P〉0.05)。洛铂组和顺铂组瘤组织中bax蛋白表达均高于对照组(P〈0.05),bcl-2蛋白表达均低于对照组(P〈0.05),但洛铂与顺铂组比较差异无统计学意义(P〉0.05)。结论洛铂具有抑制卵巢癌细胞生长的作用,其机制是通过调控凋亡基因bax和bcl-2的表达来实现的。 Objective To explore the inhibitory effects of lobaplatin and cisplatin and their regulation of apoptosis-related genes in ovarian cancer cells in nude mice. Methods SKOV3 cells were implanted into nude mice. In monotherapy treatment study, the nude mice bearing human SKOV3 cells were randomly divided into control, lobaplatin, and cisplatin groups, with 7 mice in each group. The mice in each group were received corresponding treatment. The volume of tumor and the weight of nude mice were meas- ured three times per week, respectively. Tumor inhibitory rate was calculated. The protein expressions of bax and bcl-2 were detected by flow cytometry. Results The growth inhibitory rate was 47.2% in lobaplatin group and 42. 8% in cisplatin group, without signifi- cant difference between two groups ( P 〉 0. 05 ). The expression of bcl-2 was decreased but the bax was increased in lobaplatin and ciaplatin groups compared to the control group. Conclusions Lobaplatin can significantly inhibit the growth of ovarian cancer cells, induce apoptosis by down-regulation of bcl-2 and up-regulation of bax.
出处 《中国医师杂志》 CAS 2015年第1期81-83,共3页 Journal of Chinese Physician
关键词 有机铂化合物/药理学 疾病模型 动物 卵巢肿瘤/药物疗法 /小鼠 肿瘤移植 基因 BCL-2 基因表达 细胞凋亡 Organoplatinum compounds/pharmacology Disease models, animal Ovarian neoplasms/drug therapy Mice,nude Neoplasm transplantation Genes, bcl-2 Gene expression Apoptosis
  • 相关文献

参考文献15

  • 1周恒,张晓霞.卵巢癌诊断的研究进展[J].中华临床医师杂志(电子版),2013,7(4):15-18. 被引量:18
  • 2任俊红,黄新恩,蔡炜宇,江伟,孙蔚莉,夏国豪.洛铂联合吉西他滨治疗晚期肺癌安全性的临床观察[J].肿瘤基础与临床,2007,20(6):489-490. 被引量:11
  • 3姜文奇,林桐榆,徐瑞华,管忠震.乐铂单药治疗乳腺癌的Ⅱ期临床研究[J].实用癌症杂志,1998,13(4):294-295. 被引量:38
  • 4刘思海,冯雯,朱瑞霞,付正传.洛铂、草酸铂分别联合替加氟持续泵入治疗晚期胃癌的比较研究[J].现代肿瘤医学,2008,16(10):1743-1744. 被引量:11
  • 5Wang Z, Tang X, Zhang Y, et al. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE[J]. Biomed Pharmacother,2012,66(3) :161-166.
  • 6Dai HY, Liu L, Qin SK, et al. Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell Line LOVO in vitro [ J ]. Biomed Pharmacother, 2011,65 ( 3 ) : 137- 141.
  • 7Wu Q, Qin SK, Teng FM, et al. Lobaplatin arrests cell cycle pro- gression in human hepatocellular carcinoma ceils [ J ]. J Hematol Oncol, 2010,3:43.
  • 8Huang XE, Wei GL, Huo JG, et al. Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites[J]. Asian Pac J Cancer Prey, 2013,14 (4) :2611- 2614.
  • 9Li X, Ran L, Fang W, et al. Lobaplatin arrests cell cycle progres- sion, induces apoptosis and alters the proteome in human cervical cancer cell Line CaSki[ J]. Biomed Pharmacother, 2014,68 (3) : 291-297.
  • 10Lobaplatin: D 19466[J]. Drugs R D, 2003,4(6) :369-372.

二级参考文献37

共引文献76

同被引文献23

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部